 |
Extracellular Vesicles Surface Protein Profile as Biomarkers to Characterize Allograft Rejection in Heart Transplanted Patients
Chiara Castellani, PhD, University of Padova, Padova, Italy
Moderated Q&A
Led by Stephan Ensminger, MD, DPhil, University of Lubeck, Lubeck, Germany |
 |
Intra-Subject Variance of Respiratory Oscillometry Reflects Graft Injury and is Associated with Acute Rejection and Chronic Lung Allograft Dysfunction (CLAD) Post Lung Transplant
Anastasiia Vasileva, MD, University of Toronto, Toronto, ON, Canada
Moderated Q&A
Led by Peter Hopkins, FRACP, The Prince Charles Hospital, Brisbane, Australia |
 |
Outcomes of Ventricular Assist Device Use in Children for Bridge to Heart Retransplantation
John Dykes, MD, Lucile Packard Children’s Hospital, Stanford, CA, USA
Moderated Q&A
Led by Stephan Ensminger, MD, DPhil, University of Lubeck, Lubeck, Germany |
 |
Pulmonary Endarterectomy (PEA) vs. Balloon Pulmonary Angioplasty (BPA) in Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH): Comparison of Improvements in Hemodynamics and Functional Capacity
Havard Ravnestad, MD, Oslo University Hospital, Oslo, Norway
Moderated Q&A
Led by Peter Hopkins, FRACP, The Prince Charles Hospital, Brisbane, Australia |
Message from the ISHLT2022 Program Chair
Laurie Snyder, MD, Duke University Medical Center, Durham, NC, USA
ISHLT Announcements
Greg Schultz, ISHLT CEO |